Neurovalens Receives National Sleep Foundation's Prestigious Award for SleepTech Innovation

Neurovalens Triumphs with 2024 SleepTech® Award

In an exciting development in the realm of neurotechnology, Neurovalens, a leading global health-tech company, has been awarded the highly esteemed National Sleep Foundation's (NSF) 2024 SleepTech® Award. This honor was given for their groundbreaking product, Modius Sleep, an innovative solution designed to address chronic insomnia. The award not only recognizes the technical achievements of the product but also showcases its potential impact on sleep health and overall well-being.

Introduction to Modius Sleep

Modius Sleep stands out as a noninvasive, FDA-cleared medical device that utilizes cutting-edge neurostimulation technology to enhance sleep patterns in individuals suffering from insomnia. Unlike traditional approaches that often rely on medications, Modius Sleep offers a drug-free alternative, targeting specific brain regions responsible for sleep regulation. Through its advanced technology, Modius Sleep aims to reshape how people view and manage their sleep conditions, presenting a new frontier in health-tech solutions.

Recognition and Future Engagement

Winning this prestigious award also paves the way for Neurovalens to join the National Sleep Foundation at the Consumer Electronics Show (CES) 2025 in Las Vegas. This networking opportunity will see key representatives from both organizations engage in discussions surrounding the future of sleep technology and its crucial role in bolstering brain health. Kate Willis, Neurovalens' Vice President of Commercialization, has been invited to be a panelist during this event, illustrating the product’s significance in the health tech landscape.

The panel, titled "SleepTech®: A Gateway to Brain Health," scheduled for January 7th, 2025, will explore the vital connection between sleep and cognitive wellness. Notable figures in the field, including John Lopos, CEO of the NSF, will join the conversation, underscoring the transformative potential of innovations like Modius Sleep in fostering improved brain health.

Statements from Leadership

Dr. Jason McKeown, the CEO of Neurovalens, expressed his enthusiasm regarding the award and the upcoming panel at CES 2025. He stated, "We are honored to join the National Sleep Foundation and humbled to be recognized with the prestigious SleepTech® Award. This acknowledgment reinforces our commitment to advancing sleep health through groundbreaking technology. Modius Sleep is not just improving lives—it's helping reshape the future of sleep and brain health."

In response, John Lopos echoed these sentiments, stating, "NSF is excited to host Neurovalens during our panel at CES 2025, and more broadly feature them among our other SleepTech® Award winners. Neurovalens reflects the promise SleepTech holds to improve the public's sleep and health."

Experience Modius Sleep at CES

CES attendees will have the opportunity to experience Modius Sleep firsthand at the NSF booth (#53607 in the Venetian). This interactive experience will allow individuals to learn how this innovative device is set to transform sleep health across the globe by addressing the pressing issue of chronic insomnia.

About the National Sleep Foundation

The National Sleep Foundation, established in 1990, is an independent nonprofit organization committed to enhancing health and well-being through sleep education and advocacy. With its focus on advancing sleep health research and practice, NSF continues to set standards and forge paths for innovative solutions in sleep wellness.

For further information on Modius Sleep and its impact on sleep health, visit Neurovalens' official website. The strides made by Neurovalens not only represent a significant advance in sleep technology but also reflect a broader movement towards improving public health through innovative health solutions.